BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tang W, Inagaki Y, Kokudo N, Guo Q, Seyama Y, Nakata M, Imamura H, Sano K, Sugawara Y, Makuuchi M. KL-6 mucin expression in carcinoma of the ampulla of Vater: Association with cancer progression. World J Gastroenterol 2005; 11(35): 5450-5454 [PMID: 16222735 DOI: 10.3748/wjg.v11.i35.5450]
URL: https://www.wjgnet.com/1007-9327/full/v11/i35/5450.htm
Number Citing Articles
1
Sonosuke Tanaka, Noboru Hattori, Nobuhisa Ishikawa, Hiroyasu Shoda, Atsushi Takano, Ryohei Nishino, Morihito Okada, Koji Arihiro, Kouki Inai, Hironobu Hamada, Akihito Yokoyama, Nobuoki Kohno. Krebs von den Lungen‐6 (KL‐6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancerInternational Journal of Cancer 2012; 130(2): 377 doi: 10.1002/ijc.26007
2
Nicolas Jonckheere, Isabelle Van Seuningen. The membrane-bound mucins: From cell signalling to transcriptional regulation and expression in epithelial cancersBiochimie 2010; 92(1): 1 doi: 10.1016/j.biochi.2009.09.018
3
Huanli Xu, Yoshinori Inagaki, Yasuji Seyama, Kiyoshi Hasegawa, Yasuhiko Sugawara, Guanhua Du, Fengshan Wang, Wei Tang, Norihiro Kokudo. Expression of KL-6/MUC1 in pancreatic ductal carcinoma and its potential relationship with β-catenin in tumor progressionLife Sciences 2011; 88(23-24): 1063 doi: 10.1016/j.lfs.2011.03.021
4
XIAOJUN ZENG, HUALIN TAO. Diagnostic and prognostic serum marker of cholangiocarcinoma (Review)Oncology Letters 2015; 9(1): 3 doi: 10.3892/ol.2014.2696
5
Takumi Onoyama, Kazuya Matsumoto, Hiroki Koda, Taro Yamashita, Hiroki Kurumi, Soichiro Kawata, Yohei Takeda, Kenichi Harada, Kazuo Yashima, Hajime Isomoto. Diagnostic usefulness of KL-6 concentration of bile in biliary tract cancerMolecular and Clinical Oncology 2018;  doi: 10.3892/mco.2018.1571
6
H.L. Xu, Y. Inagaki, Y. Seyama, Y. Sugawara, N. Kokudo, M. Nakata, F.S. Wang, W. Tang. Expression of KL-6 mucin, a human MUC1 mucin, in intrahepatic cholangiocarcinoma and its potential involvement in tumor cell adhesion and invasionLife Sciences 2009; 85(9-10): 395 doi: 10.1016/j.lfs.2009.07.004
7
Naoe Yanagisawa, Naohiko Koide, Harunari Fukai, Yoshinori Koyama, Yuu Ogihara, Maki Ohya. Two cases of gastric cancer with elevated serum levels of KL-6Surgical Case Reports 2024; 10(1) doi: 10.1186/s40792-024-01883-0
8
Tae Mogami, Haruya Saji, Naho Yokota, Rie Suzuki, Akiko Sukegawa, Mikiko Asai-Sato, Etsuko Miyagi, Fumiki Hirahara. Serum KL-6 for diagnosis of ovarian carcinoma associated with dermatomyositis: two case reports and characteristic clinicopathological factorsInternational Cancer Conference Journal 2012; 1(2): 83 doi: 10.1007/s13691-012-0016-3
9
Yoshinori Inagaki, Yasuji Seyama, Kiyoshi Hasegawa, Wei Tang, Norihiro Kokudo. Subcellular localization of KL-6 mucin in intraductal papillary mucinous neoplasm of the pancreasDrug Discoveries & Therapeutics 2014; 8(4): 173 doi: 10.5582/ddt.2014.01027
10
Patrick Michl, Albrecht Neesse, Thomas M. Gress. Pancreatic Cancer2010; : 233 doi: 10.1007/978-0-387-77498-5_9
11
Qian Guo, Wei Tang, Yoshinori Inagaki, Yutaka Midorikawa, Norihiro Kokudo, Yasuhiko Sugawara, Munehiro Nakata, Toshiro Konishi, Hirokazu Nagawa, Masatoshi Makuuchi. Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissuesWorld Journal of Gastroenterology 2006; 12(1): 54-59 doi: 10.3748/wjg.v12.i1.54